Edition:
United Kingdom

YiChang HEC ChangJiang Pharmaceutical Co Ltd (1558.HK)

1558.HK on Hong Kong Stock

28.00HKD
14 Dec 2018
Change (% chg)

HK$0.15 (+0.54%)
Prev Close
HK$27.85
Open
HK$27.50
Day's High
HK$28.00
Day's Low
HK$26.60
Volume
2,130,872
Avg. Vol
2,451,765
52-wk High
HK$51.60
52-wk Low
HK$23.30

Latest Key Developments (Source: Significant Developments)

YiChang HEC ChangJiang Pharmaceutical Posts 9-Mnth Net Profit Attributable Of About RMB682.5 Mln
Monday, 29 Oct 2018 

Oct 29 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd <1558.HK>::9-MNTH OPERATING REVENUE OF ABOUT RMB1,722.5 MILLION.9-MNTH NET PROFIT ATTRIBUTABLE OF ABOUT RMB 682.5 MILLION.  Full Article

Yichang HEC Changjiang Pharmaceutical Co Posts HY Profit & Total Comprehensive Income Attributable RMB634.5 Mln
Friday, 24 Aug 2018 

Aug 24 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd <1558.HK>::RECOMMENDED AN INTERIM DIVIDEND OF RMB0.40 PER SHARE.HY REVENUE RMB1,482.4 MILLION, UP 123.8 PERCENT.HY PROFIT & TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE WAS RMB634.5 MILLION, UP 110.2%.  Full Article

Guangdong Hec Technology's Unit To Buy Licenses Of Generic Drug, To Issue H-share Convertible Bonds
Tuesday, 14 Aug 2018 

Aug 14 (Reuters) - Guangdong Hec Technology <600673.SS>::SAYS UNIT YICHANG HEC CHANGJIANG PHARMA <<<1558.HK>>> PLANS TO BUY TECHNOLOGY AND RELATED LICENSES OF SIX GENERIC DRUG FOR 505.2 MILLION YUAN ($73.44 million).SAYS UNIT YICHANG HEC CHANGJIANG PHARMA PLANS TO ISSUE $400 MILLION H-SHARE CONVERTIBLE BONDS.  Full Article

Yichang Hec Changjiang Pharmaceutical Sees Increase In Profit Attributable For HY
Monday, 9 Jul 2018 

July 9 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd <1558.HK>::EXPECTED THAT GROUP WILL RECORD AN INCREASE IN PROFIT ATTRIBUTABLE OF NO LESS THAN 110% FOR HY.SEES INCREASE IN PROFIT ATTRIBUTABLE OF NO LESS THAN 110% FOR SIX MONTHS ENDED 30 JUNE 2018.EXPECTED RESULT DUE TO, AMONG OTHERS, INCREASE IN SALES VOLUME OF COMPANY'S KEY PRODUCT KEWEI.  Full Article

Yichang HEC Changjiang Pharmaceutical Updates On Proposed Transfer HEC Pharm's Interest
Tuesday, 3 Jul 2018 

July 3 (Reuters) - YiChang HEC ChangJiang Pharmaceutical Co Ltd <1558.HK>::NOTIFIED BY GUANGDONG HEC THAT, GUANGDONG HEC RECEIVED APPROVAL OF PROPOSED TRANSFER FROM CSRC ON 3 JULY 2018.UPDATES ON PROPOSED TRANSFER OF INTEREST IN CO HELD BY HEC PHARM CO LTD TO GUANGDONG HEC TECHNOLOGY HOLDING CO.  Full Article

Photo

Blackstone invests $400 million in HEC Pharm via convertible bonds

HONG KONG U.S. private equity firm Blackstone Group LP has signed a deal to invest $400 million in Hong Kong-listed YiChang HEC ChangJiang Pharmaceutical Co. via convertible bonds, HEC said Wednesday.